These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20878891)

  • 1. An improved validated ultra high pressure liquid chromatography method for separation of tacrolimus impurities and its tautomers.
    Subasranjan A; C S; Hemant R
    Drug Test Anal; 2010 Mar; 2(3):107-12. PubMed ID: 20878891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel validated ultra-performance liquid chromatography Method for separation of eszopiclone impurities and its degradants in drug products.
    Sharma N; Rao SS; Kumar ND; Reddy AM
    J AOAC Int; 2013; 96(5):981-6. PubMed ID: 24282935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated ultra high-pressure liquid chromatography method for separation of candesartan cilexetil impurities and its degradents in drug product.
    Kumar ND; Babu KS; Gosada U; Sharma N
    Pharm Methods; 2012 Jan; 3(1):31-9. PubMed ID: 23781475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination.
    Peterka TR; Lušin TT; Bergles J; Ham Z; Grahek R; Urleb U
    Acta Pharm; 2019 Sep; 69(3):363-380. PubMed ID: 31259735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated stability-indicating UPLC method for the determination of impurities in Maraviroc.
    Chilukuri M; Hussainreddy K; Narayanareddy P; Venkataramana M
    J Chromatogr Sci; 2014 Aug; 52(7):609-16. PubMed ID: 23825352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
    Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
    J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
    Papandreou G; Zorpas K; Archontaki H
    J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
    Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.
    Mohan A; Patel HB; Saravanan D
    J AOAC Int; 2011; 94(6):1800-6. PubMed ID: 22320087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method.
    Runje M; Babić S; Meštrović E; Nekola I; Dujmić-Vučinić Ž; Vojčić N
    J Pharm Biomed Anal; 2016 May; 123():42-52. PubMed ID: 26871279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of impurities level of perindopril tert-butylamine in tablets.
    Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
    J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
    Sharma N; Rao SS; Reddy AM
    J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Nageswari A; Reddy KV; Mukkanti K
    J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology.
    Barmpalexis P; Kanaze FI; Georgarakis E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1192-202. PubMed ID: 19369025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
    Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
    Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments.
    Murthy MV; Krishnaiah Ch; Srinivas K; Rao KS; Kumar NR; Mukkanti K
    J Pharm Biomed Anal; 2013 Jan; 72():40-50. PubMed ID: 23146225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.